ArticleOncotarget2016

Correction: A novel small molecule agent displays potent anti-myeloma activity by inhibiting the JAK2-STAT3 signaling pathway.

Zubin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.